Arbor Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$206K Buy
+1,605
New +$188K 0.02% 138
2022
Q3
Sell
-2,683
Closed -$245K 98
2022
Q2
$245K Buy
2,683
+1
+0% +$89 0.05% 89
2022
Q1
$220K Sell
2,682
-149
-5% -$11.7K 0.04% 112
2021
Q4
$217K Buy
2,831
+18
+0.6% +$1.43K 0.04% 108
2021
Q3
$211K Sell
2,813
-131
-4% -$9.96K 0.04% 100
2021
Q2
$229K Sell
2,944
-90
-3% -$6.69K 0.05% 99
2021
Q1
$223K Buy
3,034
+1
+0% +$74 0.05% 92
2020
Q4
$237K Sell
3,033
-51
-2% -$3.9K 0.05% 82
2020
Q3
$244K Sell
3,084
-92
-3% -$7.21K 0.06% 77
2020
Q2
$234K Buy
3,176
+1
+0% +$75 0.06% 74
2020
Q1
$233K Buy
3,175
+94
+3% +$7.39K 0.08% 70
2019
Q4
$267K Hold
3,081
0.08% 72
2019
Q3
$247K Buy
3,081
+139
+5% +$11.1K 0.08% 71
2019
Q2
$235K Buy
2,942
+1
+0% +$77 0.07% 69
2019
Q1
$233K Buy
+2,941
New +$220K 0.07% 67
2014
Q3
Sell
-7,542
Closed -$416K 49
2014
Q2
$416K Hold
7,542
0.22% 35
2014
Q1
$409K Buy
+7,542
New +$391K 0.23% 35

Other funds holding MRK

Arbor Investment Advisors's MRK Position: Q2 2026 in Review

Arbor Investment Advisors opened a new position in Merck (MRK) in Q2 2026: 1,605 shares worth $206K. The stake represents 0.02% of the portfolio and ranks #138 among its holdings. This is a return to the name: Arbor Investment Advisors previously reported a position in MRK as recently as Q2 2022.

Arbor Investment Advisors first reported a position in MRK in Q1 2014 and has held it in 17 quarters since. The position peaked at $416K in Q2 2014. 3,836 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Arbor Investment Advisors held 1,605 shares of Merck worth $206K as of Q2 2026.
  • Merck was a new Arbor Investment Advisors position in Q2 2026.
  • Merck made up 0.02% of Arbor Investment Advisors's portfolio in Q2 2026, its #138 holding.
  • Arbor Investment Advisors first reported a position in Merck in Q1 2014 and has held it in 17 quarters since.
  • Arbor Investment Advisors's Merck position peaked at $416K in Q2 2014.
  • 3,836 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Arbor Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.